Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.1.21 (
thymidine kinase
)
7,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
HIP
/PAP is a C-type lectin overexpressed in hepatocellular carcinoma (HCC). Pleiotropic biological activities have been ascribed to this protein, but little is known about the function of
HIP
/PAP in the liver. In this study, therefore, we searched for proteins interacting with
HIP
/PAP by screening a HCC cDNA expression library. We have identified the RII alpha regulatory subunit of cAMP-dependent protein kinase (PKA) as a partner of
HIP
/PAP.
HIP
/PAP and RII alpha were coimmunoprecipitated in
HIP
/PAP expressing cells. The biological relevance of the interaction between these proteins was established by demonstrating, using fractionation methods, that they are located in a same subcellular compartment. Indeed, though
HIP
/PAP is a protein secreted via the Golgi apparatus we showed that a fraction of
HIP
/PAP escaped the secretory apparatus and was recovered in the cytosol. Basal PKA activity was increased in
HIP
/PAP expressing cells, suggesting that
HIP
/PAP may alter PKA signalling. Indeed, we showed, using a
thymidine kinase
-luciferase reporter plasmid in which a cAMP responsive element was inserted upstream of the
thymidine kinase
promoter, that luciferase activity was enhanced in
HIP
/PAP expressing cells. Thus our findings suggest a novel mechanism for the biological activity of the
HIP
/PAP lectin.
...
PMID:HIP/PAP, a C-type lectin overexpressed in hepatocellular carcinoma, binds the RII alpha regulatory subunit of cAMP-dependent protein kinase and alters the cAMP-dependent protein kinase signalling. 1537 27